Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 3 (2006), Issue 11 (November)

1. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.
   FASEB J, 20(13): 2405-7. [Abstract] [Full-text]
2. Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children.
   Pediatrics, 118(5): 2014-24. [Abstract] [Full-text]
3. Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection.
   J Acquir Immune Defic Syndr, 43(3): 344-50. [Abstract] [Full-text]
4. Relations between parent and adolescent problems among adolescents presenting for family-based marijuana abuse treatment.
   Drug Alcohol Depend, 85(3): 244-54. [Abstract] [Full-text]
5. Substance use and treatment seeking in young offenders on community orders.
   J Subst Abuse Treat, 31(4): 425-32. [Abstract] [Full-text]
6. Adult social behavioral effects of heavy adolescent marijuana use among African Americans.
   Dev Psychol, 42(6): 1168-78. [Abstract] [Full-text]
7. Physicochemical and functional properties of hemp (Cannabis sativa L.) protein isolate.
   J Agric Food Chem, 54(23): 8945-50. [Abstract] [Full-text]
8. Does occasional cannabis use impact anxiety and depression treatment outcomes?: results from a randomized effectiveness trial.
   Depress Anxiety. [Abstract] [Full-text]
9. Substance use pathways to methamphetamine use among treated users.
   Addict Behav, 32(1): 24-38. [Abstract] [Full-text]
10. Explicit and implicit effects of anti-marijuana and anti-tobacco TV advertisements.
    Addict Behav, 32(1): 114-27. [Abstract] [Full-text]
11. Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers.
    Addict Behav, 32(1): 49-62. [Abstract] [Full-text]
12. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Drug Alcohol Depend, 86(1): 22-9. [Abstract] [Full-text]
13. Psychosocial correlates of substance use in adolescence: a cross-national study in six European countries.
    Drug Alcohol Depend, 86(1): 67-74. [Abstract] [Full-text]
14. Prospective validation of substance abuse severity measures from administrative data.
    Drug Alcohol Depend, 86(1): 37-45. [Abstract] [Full-text]
15. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.
    Schizophr Res, 88(1): 142-50. [Abstract] [Full-text]
16. A comparison of alcohol and drug use among dental undergraduates and a group of non-medical, professional undergraduates.
    Br Dent J, 201(9): 581-4; discussion 576. [Abstract] [Full-text]
17. Alcohol and drug use among dental and law undergraduates.
    Br Dent J, 201(9): 576. [Abstract] [Full-text]
18. A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China.
    J Ethnopharmacol, 108(3): 414-22. [Abstract] [Full-text]
19. Item response theory analysis of diagnostic criteria for alcohol and cannabis use disorders in adolescents: implications for DSM-V.
    J Abnorm Psychol, 115(4): 807-14. [Abstract] [Full-text]
20. Diffusion Tensor Imaging of the Corpus Callosum in Addiction.
    Neuropsychobiology, 54(2): 107-113. [Abstract] [Full-text]
21. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Neuropsychopharmacology, 31(12): 2748-57. [Abstract] [Full-text]
22. Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
    Springer Semin Immunopathol, 28(3): 281-7. [Abstract] [Full-text]
23. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
    Fundam Clin Pharmacol, 20(6): 549-62. [Abstract] [Full-text]
24. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Psychopharmacology (Berl), 189(4): 505-16. [Abstract] [Full-text]
25. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Psychopharmacology (Berl), 189(4): 517-30. [Abstract] [Full-text]
26. Differences in temperament, character and psychopathology among subjects with different patterns of cannabis use.
    Psychopathology, 40(1): 29-34. [Abstract] [Full-text]
27. Evaluation of herbal cannabis characteristics by medical users: a randomized trial.
    Harm Reduct J, 3: 32. [Abstract] [Full-text]
28. Altered regional blood volume in chronic cannabis smokers.
    Exp Clin Psychopharmacol, 14(4): 422-8. [Abstract] [Full-text]
29. Socio-economic position and adolescents' health in Italy: the role of the quality of social relations.
    Eur J Public Health, 16(6): 627-32. [Abstract] [Full-text]
30. Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
    Med Mycol, 44(8): 777-82. [Abstract] [Full-text]
31. Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis.
    Psychol Med, 36(12): 1717-1725. [Abstract] [Full-text]
32. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents.
    Am J Med Genet B Neuropsychiatr Genet, 141(8): 895-901. [Abstract] [Full-text]
33. Drug production, trafficking and trade in Asia and Pacific Island countries.
    Drug Alcohol Rev, 25(6): 647-50. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.